Search Results - "Moskowitz, S.M"

WS07.2 An anti-persister strategy for the treatment of chronic Pseudomonas aeruginosa infections by Koeva, M, Gutu, A.D, Hebert, W, Yonker, L.M, Moskowitz, S.M, O'Toole, G.A, Ausubel, F.M, Joseph-McCarthy, D

Get full text

WS12.5 The CF-CARES primary palliative care model: a CF-specific structured assessment of symptoms, distress and coping by Friedman, D, Linnemann, R.W, Georgiopoulos, A.M, Altstein, L, Islam, S, Bach, K.-T, Lamb, C, Volpe, J, Doolittle, C, St. John, A, O'Malley, P.J, Sawicki, G.S, Yonker, L.M, Moskowitz, S.M

Get full text

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele by Middleton, Peter G, Mall, Marcus A, Dřevínek, Pavel, Lands, Larry C, McKone, Edward F, Polineni, Deepika, Ramsey, Bonnie W, Taylor-Cousar, Jennifer L, Tullis, Elizabeth, Vermeulen, François, Marigowda, Gautham, McKee, Charlotte M, Moskowitz, Samuel M, Nair, Nitin, Savage, Jessica, Simard, Christopher, Tian, Simon, Waltz, David, Xuan, Fengjuan, Rowe, Steven M, Jain, Raksha

“…Triple treatment with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis who had one Phe508del allele and a minimal-function mutation…”
Get full text

PRS77 Application of the Cfq-R-8D to Estimate Utility Benefit of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in People with Cystic Fibrosis (CF) by McGarry, L., Lopez, A., Booth, J., Yuan, J., Morlando Geiger, J., Lou, Y., Moskowitz, S.M.

Get full text

P221 Impact of elexacaftor/tezacaftor/ivacaftor triple combination therapy on health-related quality of life in people with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a Phase 3 clinical study by Fajac, I., Van Brunt, K., Daines, C., Durieu, I., Goralski, J., Heijerman, H., Knoop, C., Majoor, C., Booth, J., Moskowitz, S.M., Savage, J., Wang, C., Quittner, A.

Get full text

WS19.6 Impact of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) triple combination therapy on health-related quality of life (HRQoL) in people with cystic fibrosis (pwCF) homozygous for F508del (F/F): results from a Phase 3 clinical study by Majoor, C., Van Brunt, K., Daines, C., Durieu, I., Fajac, I., Goralski, J., Heijerman, H., Knoop, C., Booth, J., Moskowitz, S.M., Savage, J., Wang, C., Quittner, A.

Get full text

Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel : multiple allelic mutations of the IDUA gene in a small geographic area by BACH, G, MOSKOWITZ, S. M, TIEU, P. T, MATYNIA, A, NEUFELD, E. F

“…The mutations underlying Hurler syndrome (mucopolysaccharidosis IH) in Druze and Muslim Israeli Arab patients have been characterized. Four alleles were…”
Get full text

Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog by Stoltzfus, L J, Sosa-Pineda, B, Moskowitz, S M, Menon, K P, Dlott, B, Hooper, L, Teplow, D B, Shull, R M, Neufeld, E F

“…alpha-L-Iduronidase is a lysosomal enzyme, the deficiency of which causes mucopolysaccharidosis I (MPS I); a canine MPS I colony has been bred to test…”
Get full text

Techniques For Prediction Of Large Nonanalytic Reflector Antenna Performance by Moskowitz, S.M., Bailey, M.c.

Get full text